Institute for Applied Cancer Science
NDC Leadership
The multidisciplinary multi-institutional team of experienced scientists has established this consortium to focus their combined respective research strengths on neurodegeneration.
This effort will be brought forward under the leadership of a formidable team including:
Baylor College of Medicine:
- Hugo Bellen, D.V.M., Ph.D., (neurodegenerative disease and developmental neurological disorders)
- Juan Botas, Ph.D., (neurodegenerative diseases)
- Joanna Jankowsky, Ph.D., (models of Alzheimer’s disease)
- Hui Zheng, Ph.D., Baylor College of Medicine (models of Alzheimer’s disease)
- Huda Zoghbi, M.D, Baylor College of Medicine (neurodegenerative disease and developmental neurological disorders)
MD Anderson:
- Lynda Chin, M.D., (functional genomics and bioinformatics and cancer biology)
- Ronald DePinho, M.D., (genetics, comparative genomics, biology of aging, models of cancer and aging)
- Giulio Draetta, M.D., Ph.D., (translational research, drug discovery)
- Ming-Kuei Jang, Ph.D., (neurobiology, Alzheimer's disease, drug discovery and development )
- Philip Jones, Ph.D.,(drug discovery and development)
Picower Institute for Learning and Memory at MIT:
- Li-Huei Tsai, Ph.D., (neurobiology, learning and memory and neurodegeneration)